Check-Cap Ltd
$0.91 - 20-11-2024 4 p.m. ET
Company Profile
Check-Cap is a clinical stage medical diagnostics company aiming to redefine colorectal cancer (CRC) preventionthrough the introduction of C-Scan®, thefirst and onlypatient-friendly preparation-freescreening test to detect polypsbeforethey may transform into cancer. The Company'sdisruptivecapsule-basedscreening technology aims to significantly increasescreening adherenceworldwide and help millions of people tostay healthy through preventive CRC screening. C-Scan uses an ultra-low dose X-ray capsule, an integrated positioning, control and recording system, as well as proprietary software to generate a 3D map of the inner lining of the colon. C-Scan is non-invasive and requires no preparation or sedation, allowing the patients to continue their daily routine with no interruption as the capsule is propelled through the gastrointestinal tract by natural motility.
- Health Technology
- Medical Specialties
- Manufacturing
- Irradiation Apparatus Manufacturing